TNYA Valuation

Add to Watchlist

Advanced Chart

0.000

0(0.000%)1D

Overview
Forecast
Valuation
Earnings

TNYA Relative Valuation

TNYA's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, TNYA is overvalued; if below, it's undervalued.

Historical Valuation

Tenaya Therapeutics Inc (TNYA) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -2.72. The fair price of Tenaya Therapeutics Inc (TNYA) is between to according to relative valuation methord.

Relative Value

Fair Zone

Current Price：0.83

Fair

Trailing

Forward

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

1.18

P/B

Median3y

1.28

Median5y

1.35

-60.72

FCF Yield

Median3y

-65.42

Median5y

-54.07

Competitors Valuation Multiple

The average P/S ratio for TNYA's competitors is 7.47, providing a benchmark for relative valuation. Tenaya Therapeutics Inc Corp (TNYA) exhibits a P/S ratio of 0.00, which is -100.00% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap

TNYA.O

Tenaya Therapeutics Inc

Loss

Average P/S: 7.47

135.53M